Success Story

CHIMIE &
ENVIRONNEMENT

BIOTECHNOLOGY &
WATER, SLUDGE, AIR & EMISSIONS

SOILS & SEDIMENTS

GOOD HEALTH & WELL-BEING,
RESPONSIBLE CONSUMPTION & PRODUCTION,
CLEAN WATER & SANITATION,
INDUSTRY, INNOVATION & INFRASTRUCTURE &
LIFE BELOW WATER

MEDIX

HOW CAN ONE TREAT PHARMACEUTICAL MICROPOLLUTANTS FOUND IN WASTEWATER THAT ARE GENERATED, NOTABLY, BY HEALTHCARE ESTABLISHMENTS?

GreenWin presents MEDIX :

MEDIX was developed in order to address the treatment of micropollutants of
pharmaceutical origin in our wastewater, micropollutants that have a recognised
negative impact on the ecosystems, fauna and flora that are subjected to them, as
well as on mankind. Through a novel process that is flexible, modular and energyefficient and entirely based on the biological degradation of micropollutants, MEDIX
is able to arrest pollution at source.

Having taken the gamble to anticipate legislation, MEDIX offers an ideal solution for
addressing this public health linked problem.

Les « + » :

In comparison with processes for the treatment of micropollutants that are already known and mastered, MEDIX doesn’t generate highly toxic supplementary by-products.
In addition MEDIX consumes less energy and offers higher yields. Its achievements have been validated by an independent laboratory.
MEDIX offers simple and modular integration.
MEDIX benefits from the know-how of the John Cockerill Balteau company

Project supported by the following consortium:

Project sponsor: Balteau (CMI Group)
The company: BALTEAU; SYMBIO
CRA: CEBEDEAU
Universities and Higher Education Institutions ULg -CART

MEDIX

Cookie management